{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/NUVB/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-17T03:57:27.954Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9688,"canonical_name":"Nuvation Bio Inc.","cik":"0001811063","uei":null,"lei":null,"duns":null,"ticker":"NUVB"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"clinical":3,"sec":21},"count":24,"timeline":[{"ts":"2026-09-22","kind":"clinical.trial","reporter":"Nuvation Bio Inc.","title":"Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease","security_title":"PHASE2","status":"NOT_YET_RECRUITING","accession_number":"NCT07703436","excerpt":"[\"Grade 2 IDH1-mutant Glioma\",\"Grade 3 IDH1-mutant Glioma\",\"Glioma\",\"IDH1-mutant Glioma\",\"Oligodendroglioma\",\"Oligodendroglioma IDH-1 Mutant and 1/p19q-codeleted\",\"Astrocytoma IDH Mutant Grade 3\",\"Astrocytoma IDH Mutant Grade 2\"]","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Nuvation Bio Inc. — 2026-08-06","url_slug":"/sec/cik-0001811063/10-q/0001193125-26-336646","accession_number":"0001193125-26-336646","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — Nuvation Bio Inc. — 2026-08-06","url_slug":"/sec/cik-0001811063/8-k/0001193125-26-336751","accession_number":"0001193125-26-336751","importance":35},{"ts":"2026-08-03","kind":"clinical.trial","reporter":"Nuvation Bio Inc.","title":"Study on the Effect of Famotidine on Pharmacokinetics of Taletrectinib","security_title":"PHASE1","status":"NOT_YET_RECRUITING","accession_number":"NCT07742384","excerpt":"[\"Healthy Adult Participants\"]","importance":30},{"ts":"2026-07-17","kind":"clinical.trial","reporter":"Nuvation Bio Inc.","title":"Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07712757","excerpt":"[\"Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation\",\"Astrocytoma IDH Mutant Grade 2\",\"Oligodendroglioma\",\"Oligodendroglioma IDH-mutant and 1p/19q-codeleted\",\"IDH-mutant Gliomas\"]","importance":60},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — Nuvation Bio Inc. — 2026-07-17","url_slug":"/sec/cik-0001811063/4/0002039891-26-000008","accession_number":"0002039891-26-000008","importance":30},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"Sauvage Philippe","title":"Chief Financial Officer","shares":39999,"price_per_share":2.17,"usd_value":86798,"security_title":"Class A Common Stock","importance":15.08679783},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"Sauvage Philippe","title":"Chief Financial Officer","shares":1,"price_per_share":1.97,"usd_value":2,"security_title":"Class A Common Stock","importance":15.00000197},{"ts":"2026-07-06","kind":"sec.filing","form_type":"8-K","title":"8-K — Nuvation Bio Inc. — 2026-07-06","url_slug":"/sec/cik-0001811063/8-k/0001193125-26-296398","accession_number":"0001193125-26-296398","importance":35},{"ts":"2026-06-30","kind":"sec.filing","form_type":"8-K","title":"8-K — Nuvation Bio Inc. — 2026-06-30","url_slug":"/sec/cik-0001811063/8-k/0001193125-26-290823","accession_number":"0001193125-26-290823","importance":35},{"ts":"2026-06-29","kind":"sec.filing","form_type":"305B2","title":"305B2 — Nuvation Bio Inc. — 2026-06-29","url_slug":"/sec/cik-0001811063/305b2/0001193125-26-286283","accession_number":"0001193125-26-286283","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"424B5","title":"424B5 — Nuvation Bio Inc. — 2026-06-29","url_slug":"/sec/cik-0001811063/424b5/0001193125-26-286494","accession_number":"0001193125-26-286494","importance":30},{"ts":"2026-06-23","kind":"sec.form144","reporter":"KERRY WENTWORTH","title":"Officer","shares":63000,"usd_value":362880,"security_title":"COMMON","approx_sale_date":"2026-06-23","accession_number":"0001950047-26-006425","importance":40.072576},{"ts":"2026-06-23","kind":"sec.form144","reporter":"PHILIPPE SAUVAGE","title":"Officer","shares":47668,"usd_value":274568,"security_title":"COMMON","approx_sale_date":"2026-06-23","accession_number":"0001950047-26-006424","importance":40.054913536},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Markel Stacy","title":"CHIEF PEOPLE OFFICER","shares":125000,"price_per_share":6.0255,"usd_value":753188,"security_title":"Class A Common Stock","importance":35.7531875},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Wentworth Kerry","title":"CHIEF REGULATORY OFFICER","shares":63000,"price_per_share":6.0189,"usd_value":379191,"security_title":"Class A Common Stock","importance":35.3791907},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Sauvage Philippe","title":"Chief Financial Officer","shares":47668,"price_per_share":6.0076,"usd_value":286370,"security_title":"Class A Common Stock","importance":35.2863702768},{"ts":"2026-06-23","kind":"sec.filing","form_type":"144","title":"144 — Nuvation Bio Inc. — 2026-06-23","url_slug":"/sec/cik-0001811063/144/0001950047-26-006424","accession_number":"0001950047-26-006424","importance":30},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"Wentworth Kerry","title":"CHIEF REGULATORY OFFICER","shares":63000,"price_per_share":2.93,"usd_value":184590,"security_title":"Class A Common Stock","importance":15.18459},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"Markel Stacy","title":"CHIEF PEOPLE OFFICER","shares":90380,"price_per_share":1.87,"usd_value":169011,"security_title":"Class A Common Stock","importance":15.1690106},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"Sauvage Philippe","title":"Chief Financial Officer","shares":47668,"price_per_share":2.17,"usd_value":103440,"security_title":"Class A Common Stock","importance":15.10343956},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"Markel Stacy","title":"CHIEF PEOPLE OFFICER","shares":34620,"price_per_share":1.74,"usd_value":60239,"security_title":"Class A Common Stock","importance":15.0602388},{"ts":"2026-06-11","kind":"sec.filing","form_type":"4","title":"4 — Nuvation Bio Inc. — 2026-06-11","url_slug":"/sec/cik-0001811063/4/0002007102-26-000004","accession_number":"0002007102-26-000004","importance":30},{"ts":"2026-06-09","kind":"sec.insider.p","reporter":"Mashal Robert","title":"","shares":25000,"price_per_share":4.73,"usd_value":118250,"security_title":"Class A Common Stock","importance":50.11825}]}